Showing results (111-120 of 580) with videos related to

Sort By:
Pageof 58
Clinical Science (London, England : 1979)|February 9, 2006
Adiponectin: a key adipocytokine in metabolic syndromeYoshihisa Okamoto, Shinji Kihara, Tohru Funahashi, et al.
Circulation Research|August 24, 2002
Innate and adaptive immunity in the pathogenesis of atherosclerosisGöran K Hansson, Peter Libby, Uwe Schönbeck, et al.
European Heart Journal|January 13, 2018
Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromesRamon A Partida, Peter Libby, Filippo Crea, et al.
Infection and Immunity|June 18, 2002
Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infectionJessica B Sakash, Gerald I Byrne, Andrew Lichtman, et al.
European Heart Journal|September 11, 2019
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosisPaul M Ridker, Jean G MacFadyen, Tom Thuren, et al.
Circulation Research|January 21, 2006
A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signalingKiyoshi Takayama, Galina K Sukhova, Michael T Chin, et al.
Clinical Science (London, England : 1979)|July 22, 2006
Influence of pre-analytical and analytical factors on soluble CD40L measurementsNerea Varo, Rebecca Nuzzo, Cristina Natal, et al.
Current Opinion in Lipidology|July 7, 2017
Mechanisms of erosion of atherosclerotic plaquesThibaut Quillard, Grégory Franck, Thomas Mawson, et al.
European Heart Journal|April 18, 2012
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaquePaolo G Camici, Ornella E Rimoldi, Oliver Gaemperli, et al.
The American Journal of Cardiology|July 6, 2010
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)Paul M Ridker, Jean MacFadyen, Peter Libby, et al.
Pageof 58